孕产妇毒理学测试政策的内容分析,以告知物质使用障碍识别中的公平性
Leah L Habersham1, Sugy Choi2, Michelle Gelband3
1Department of Psychiatry, Department of Obstetrics, Gynecology, & Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Leah.Habersham@mountsinai.org.
Maternal and child health journal
|May 16, 2025
概括
在纽约市,围产期物质使用和物质使用障碍 (SUDs) 的医院政策有很大的差异. 制定基于证据的指导方针对于公平的孕产妇查和改善结果至关重要.
科学领域:
- 公共卫生 公共卫生
- 孕产妇健康 孕产妇健康
- 药物使用障碍 药物使用障碍
背景情况:
- 周产期物质使用和物质使用障碍 (SUDs) 影响母亲和婴儿的健康.
- 现有的医院对孕产妇查的政策缺乏标准化,并可能使耻辱感延续.
- 公平的查对于及时干预和改善二结果至关重要.
研究的目的:
- 分析纽约市 (NYC) 现有的医院级政策,涉及围产期物质使用和SUDs.
- 为制定公平的医院政策提供指南,用于对孕产妇使用物质查.
- 确定当前政策方法中的最佳实践和差距.
主要方法:
- 纽约市七个医院水平的孕产妇毒理学政策 (2021-2022) 的定性主题内容分析.
- 政策使用健康公平影响评估框架进行分析.
- 两位研究人员进行了主题分析,另外两位研究人员审查了已识别的主题.
主要成果:
- 在七个政策中确定了四种不同的政策方法 (A,B,C,D类型).
- 政策在查工具,毒理学测试,同意和转介流程方面有所不同.
- 一些政策有可能通过关注非指示性高风险特征来加强耻辱感.
结论:
- 需要基于证据的多学科指导方针,用于围产期物质使用和SUD管理.
- 建议整合查,简短干预和转诊治疗 (SBIRT),而不是仅仅依赖毒理学测试.
- 调查结果可以为制定公平政策提供信息,以改善母亲和婴儿的结果.
相关概念视频
Substance Use Disorders Affecting Sleep
151
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
151
Drug Abuse and Addiction: Pharmacological Phenomena
413
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
413
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Mutagenicity and Carcinogenicity
1.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.1K


